01:00 PM EST, 01/23/2025 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) reported fiscal Q3 earnings Thursday of $0.20 per diluted share, up from $0.19 a year earlier.

Three analysts polled by FactSet expected $0.21.

Revenue for the quarter ended Dec. 31 was $977 million, compared with $843 million a year earlier.

Analysts surveyed by FactSet expected $950.5 million.

RDY shares were down 5.2% in recent trading.

Price: 14.31, Change: -0.79, Percent Change: -5.20